Proactively increase diversity tracking in your clinical trials
Get visibility into your progress toward diversity goals when patients are in the enrollment funnel
To generate the most relevant data on the efficacy of a therapy or medical device, clinical trial participants need to represent the diverse population that will eventually use it. Per FDA draft guidance, sponsors will be required to create and implement Race and Ethnicity Diversity Plans for phase 3 studies, and other pivotal studies, of new therapies.
As global diversity measures continue to take shape, it’s critical that sponsors ensure their clinical trial technology has diversity reporting capabilities to track progress toward these initiatives – and to inform early interventions as needed.
Request a Demo of StudyTeam Diversity Reports
Use StudyTeam to track progress toward your diversity goals during pre-screening
Sponsors who use StudyTeam Diversity Reports access insights about:
-
overall trial performance
-
I/E criteria failures
-
reasons potential patients decline to participate
All of these insights are categorized by race and ethnicity. This enables you to pinpoint diversity challenges earlier in the enrollment funnel, whether specific I/E criteria are disproportionately affecting certain populations or whether specific patient populations are declining to participate in your trial for reasons that could be addressed.
Gain actionable insights earlier
Identify causes of underrepresentation
Track progress toward your diversity goals
About StudyTeam
StudyTeam, our cloud-based patient enrollment management platform, enables sites and sponsors to collaborate more effectively on clinical trials. The goal? Accelerating the development of new and life-saving therapies.
Get strategic. Enroll more representative patient groups.
With StudyTeam, it's easier for sites to log and share the diversity data sponsors need to meet enrollment goals.